Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The agency has announced the creation of the Combination Products Policy Council to address issues related to combination products.

FDA Creates Combination Products Council

Texture analyzers can be used to evaluate wall hardness and elasticity of softgel capsules.

Best Practice: Testing Softgel Capsules

Consider the 3 Ps (product, process, and patient) when choosing a parenteral packaging material.

Best Practice: Choosing Glass Or Polymer For Parenteral Packaging

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Even though the organizers of New York’s Tribeca Film Festival decided not to air the anti-vaccine film by discredited British researcher Andrew Wakefield, the so-called documentary is getting a healthy run and further perpetuating the myth of a link between childhood vaccination and autism.

Anti-Vaccine Movement Rears Its Ugly Head Again

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Industry experts and FDA’s Office of Pharmaceutical Quality discuss the challenges, trends, and regulations involved in ensuring quality in solid and semi-solid dosage forms.

Ensuring Quality in Solid and Semi-Solid Dosage Forms

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Pharmaceutical Technology spoke with Bill Randolph, vice-president, Technical Services, Janssen Supply Chain, about some of the considerations for technology transfer of a continuous, solid-dosage manufacturing process and what he sees as the outlook for continuous manufacturing.

Continuous Manufacturing Eases Scale Up for Solid Dosage

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.

Conjugation Chemistry with Highly Potent Compounds

Global outbreaks energize vaccine R&D and drive production modernization.

Vaccine Development Faces  Urgency and Challenges

Pharmaceutical Technology spoke with FDA to get the agency’s insights on how the industry can ensure quality in solid and semi-solid dosage products.

FDA Insights on Quality in Solid Dosage Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

At DCAT's annual meeting, Bill Downey, president of the market research firm High Tech Business Decisions, summarized results from its latest survey on biopharmaceutical outsourcing.